Literature DB >> 19649559

Surgical strategy for mucin-producing bile duct tumor.

Masayuki Ohtsuka1, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Atsushi Kato, Hideyuki Yoshitomi, Katsunori Furukawa, Noboru Mitsuhashi, Dan Takeuchi, Tsukasa Takayashiki, Kosuke Suda, Masaru Miyazaki.   

Abstract

Tumors with copious mucin production within the intra- or extrahepatic bile ducts have been reported as mucin-producing bile duct tumors (MPBTs). Because mucin produced by these tumors causes recurrent cholangitis and obstructive jaundice, surgical resection should be indicated even if these tumors are regarded as benign. In order to choose the appropriate surgical procedure, exact preoperative assessment of tumor location and cancer extension is important, especially evaluation of the extent of superficial spreading through cholangioscopic observation and biopsy. In principle, MPBTs should be resected in a manner similar to that employed for other types of bile duct carcinomas. That is, major hepatectomy with or without extrahepatic bile duct resection or pancreaticoduodenectomy should be chosen as the surgical procedure, and intraoperative frozen section at the stumps of the bile duct is essential. On the other hand, when precise diagnosis is completed preoperatively and the lesion is diagnosed as adenoma or carcinoma with invasion confined to the ductal wall and limited superficial spreading, limited resections preserving organ functions as much as possible can be considered as a choice among surgical procedures. All ten patients with MPBT resected at our institution according to these strategies are still alive without tumor recurrence, with a median survival of 48.0 months.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19649559     DOI: 10.1007/s00534-009-0152-0

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  4 in total

1.  Intraductal papillary neoplasm of the bile duct accompanying biliary mixed adenoneuroendocrine carcinoma.

Authors:  Ichiro Onishi; Hirohisa Kitagawa; Kenichi Harada; Syogo Maruzen; Seisyo Sakai; Isamu Makino; Hironori Hayashi; Hisatoshi Nakagawara; Hidehiro Tajima; Hiroyuki Takamura; Takashi Tani; Masato Kayahara; Hiroko Ikeda; Tetsuo Ohta; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

Review 2.  Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm.

Authors:  Yasuni Nakanuma; Yuko Kakuda; Katsuhiko Uesaka
Journal:  Gut Liver       Date:  2019-11-15       Impact factor: 4.519

3.  The outcome of ipsilateral hemihepatectomy in mucin-producing bile duct tumors.

Authors:  Xin-wei Yang; Jue Yang; Liang Li; Xing-zhou Yan; Bao-hua Zhang; Feng Shen; Meng-chao Wu
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

Review 4.  Intraductal papillary neoplasms of the bile duct.

Authors:  Masayuki Ohtsuka; Hiroaki Shimizu; Atsushi Kato; Hideyuki Yoshitomi; Katsunori Furukawa; Toshio Tsuyuguchi; Yuji Sakai; Osamu Yokosuka; Masaru Miyazaki
Journal:  Int J Hepatol       Date:  2014-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.